Trader Joe’s recalls salad due to contamination

FAN Editor

A Trader Joe’s salad is being recalled because the dressing may be contaminated with foreign material, according to federal health officials. 

The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) issued a health alert for the Trader Joe’s Crunchy Slaw with Chicken, Crispy Noodles & Peanut Dressing, which has been pulled from store shelves in five states. 

CLICK HERE TO READ MORE ON FOX BUSINESS

According to the health alert, the “Food and Drug Administration (FDA) regulated salad dressing that has been recalled by the producer due to concerns that the salad dressing may contain hard plastic.”  

The issue was discovered when an FSIS-inspected establishment was notified by its salad dressing supplier.  

Crunchy Slaw with Chicken, Crispy Noodles & Peanut Dressing

Crunchy Slaw with Chicken, Crispy Noodles & Peanut Dressing (Trader Joe’s)

Trader Joe’s issued a similar note on its website saying the company has also been notified by its supplier regarding the recall, which is impacting stores in Arizona, California, New Mexico, Nevada and Utah.  

Shoppers going in and out of Trader Joe's grocery store on a sunny summer day on July 23, 2011, in Fair Oaks, California.

Shoppers going in and out of Trader Joe’s grocery store on a sunny summer day on July 23, 2011, in Fair Oaks, California. ( )

FSIS also posted a picture of the affected product’s label. It was sold with best-by dates of March 9, 2022 – March 12, 2022. 

GET FOX BUSINESS ON THE GO BY CLICKING HERE 

There have been no confirmed reports of adverse reactions related to the recalled product, although “anyone concerned about an illness should contact a health care provider,” according to FSIS. 

The products should be thrown away or returned, according to the agency. 

Free America Network Articles

Leave a Reply

Next Post

Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants

Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. “I think we’re going to submit to FDA a significant progress of data about […]